Carregant...
Surgery for Distant Melanoma Metastasis
Traditionally, distant metastatic melanoma has a poor prognosis due to lack of efficacious, FDA-approved systemic therapy and the limited use of surgical resection as a therapeutic option. More recently, new biologic therapies such as vemurafenib (Zelboraf) and ipilimumab (Yervoy) have showed strong...
Guardat en:
| Autors principals: | , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2012
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3346255/ https://ncbi.nlm.nih.gov/pubmed/22453019 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/PPO.0b013e31824bc981 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|